Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study - 28/02/18
Doi : 10.1016/j.jaci.2017.05.031
Katrina Abuabara, MD, MA a 
, Ole Hoffstad, MS b, Andrea B. Troxel, ScD c, Joel M. Gelfand, MD, MSCE b, d, Charles E. McCulloch, PhD e, David J. Margolis, MD, PhD b, d
, Ole Hoffstad, MS b, Andrea B. Troxel, ScD c, Joel M. Gelfand, MD, MSCE b, d, Charles E. McCulloch, PhD e, David J. Margolis, MD, PhD b, d a Department of Dermatology, University of California–San Francisco, San Francisco, Calif
e Department of Epidemiology and Biostatistics, University of California–San Francisco, San Francisco, Calif
b Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pa
d Department of Dermatology, University of Pennsylvania, Philadelphia, Pa
c Division of Biostatistics, New York University, New York, NY
| This work was supported by the National Institutes of Health National Center for Advancing Translational Sciences (UCSF-CTSI Grant Number KL2 TR000143) and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR056755 and K24 AR064310). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The PEER study was funded by Valeant Pharmaceuticals International through a grant to the Trustees of the University of Pennsylvania and D.J.M. Valeant had no role in the design and conduct of the study; collection, management, analysis and interpretation of data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. |
|
| Disclosure of potential conflict of interest: J. Gelfand has received grants from Regeneron and Sanofi and personal fees from Sanofi; also has consulted or received grants from a variety of companies that conduct work in psoriasis (he does not think it is relevant to this work so they are not listed). K. Abuabara and C. McCulloch have received a grant from the National Institutes of Health for this work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 2
P. 778 - février 2018 Retour au numéro
Article précédent
- Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells
- Véronique Schulten, Victoria Tripple, Grégory Seumois, Yu Qian, Richard H. Scheuermann, Zheng Fu, Michela Locci, Sandy Rosales, Pandurangan Vijayanand, Alessandro Sette, Rafeul Alam, Shane Crotty, Bjoern Peters
- Dose of allergens in a peanut snack (Bamba) associated with prevention of peanut allergy
- James P. Hindley, Stephanie Filep, Denise S. Block, Eva M. King, Martin D. Chapman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?